BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Fidia Farmaceutici, S.p.A. 

Via Ponte della Fabbrica 3/A

Abano Terme  Padova  35031  Italy
Phone: 39-049-8232111 Fax: 39-049-810653


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Fidia Farmaceutici, S.p.A. To Attend The 32nd Annual J.P. Morgan Investors Healthcare Conference 1/6/2014 6:18:15 AM    More...
Fidia Farmaceutici, S.p.A. to Distribute and Promote HYALGAN(R) (sodium hyaluronate) for Treatment of Osteoarthritis 9/26/2011 12:13:36 PM    More...
Sanofi Release: HYALGAN(R) (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici, S.p.A. 9/15/2011 10:59:53 AM    More...
Anika Therapeutics (ANIK) Buys Italian Firm, Fidia Farmaceutici, S.p.A. for $34 Million 1/4/2010 6:55:40 AM    More...
Fidia Farmaceutici, S.p.A. Release: Fidia Farmaceutici, S.p.A.'s European Patent on Cross-Linked Gel Slurries Has Been Entirely Revoked by the EPO Board of Appeal 12/2/2008 9:13:14 AM    More...
APR Applied Pharma Research S.A. Receive IND Approval From FDA for a New NSAID Matrix Patch Product 11/17/2008 8:43:10 AM    More...
Akorn, Inc. (AKRN) Signs A Definitive Agreement With Fidia Farmaceutici, S.p.A. To Develop Four ANDA Drug Products For Commercialization 5/2/2006 11:45:57 AM    More...
Akorn, Inc. (AKRN) Signs Letter Of Intent With Fidia Farmaceutici, S.p.A. To Develop Four ANDA Drug Products For Commercialization 10/19/2005 5:13:21 PM    More...

//-->